{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:19:16Z","timestamp":1760833156635,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.bmcl.2021.128464","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T10:48:37Z","timestamp":1637318917000},"page":"128464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Design, synthesis and activity evaluation of prodrug form JBP485 and Vitamin E for alleviation of NASH"],"prefix":"10.1016","volume":"56","author":[{"given":"Bin","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeyao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxia","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bmcl.2021.128464_b0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.bmcl.2021.128464_b0010","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.bbadis.2015.05.015","article-title":"Recent insights on the role of cholesterol in non-alcoholic fatty liver disease","volume":"1852","author":"Arguello","year":"2015","journal-title":"Biochim et Biophys Acta (BBA) \u2013 Mol Basis Dis"},{"key":"10.1016\/j.bmcl.2021.128464_b0015","doi-asserted-by":"crossref","first-page":"101153","DOI":"10.1016\/j.molmet.2020.101153","article-title":"Nuclear hormone and peptide hormone therapeutics for NAFLD and NASH","volume":"46","author":"Finan","year":"2021","journal-title":"Mol Metabol"},{"issue":"21","key":"10.1016\/j.bmcl.2021.128464_b0020","doi-asserted-by":"crossref","first-page":"12748","DOI":"10.1021\/acs.jmedchem.0c01065","article-title":"Discovery and optimization of non-bile Acid FXR agonists as preclinical candidates for the treatment of nonalcoholic steatohepatitis","volume":"63","author":"Li","year":"2020","journal-title":"J Med Chem"},{"issue":"29","key":"10.1016\/j.bmcl.2021.128464_b0025","doi-asserted-by":"crossref","first-page":"5250","DOI":"10.2174\/13816128113199990344","article-title":"Pathophysiology of NASH: perspectives for a targeted treatment","volume":"19","author":"Fabio","year":"2013","journal-title":"Curr Pharm Des"},{"issue":"7","key":"10.1016\/j.bmcl.2021.128464_b0030","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1089\/ars.2013.5486","article-title":"Reactive oxygen and nitrogen species in steatotic hepatocytes: a molecular perspective on the pathophysiology of ischemia-reperfusion injury in the fatty liver","volume":"21","author":"Reiniers","year":"2014","journal-title":"Antioxid Redox Signal"},{"issue":"40","key":"10.1016\/j.bmcl.2021.128464_b0035","doi-asserted-by":"crossref","first-page":"10458","DOI":"10.1021\/acs.jafc.8b04210","article-title":"Black sesame seeds ethanol extract ameliorates hepatic lipid accumulation, oxidative stress, and insulin resistance in fructose-induced nonalcoholic fatty liver disease","volume":"66","author":"Yang","year":"2018","journal-title":"J Agric Food Chem"},{"issue":"5","key":"10.1016\/j.bmcl.2021.128464_b0040","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.aohep.2019.11.007","article-title":"Peroxisomal footprint in the pathogenesis of nonalcoholic steatohepatitis","volume":"19","author":"Islam","year":"2020","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.bmcl.2021.128464_b0045","doi-asserted-by":"crossref","first-page":"154519","DOI":"10.1016\/j.cyto.2018.08.013","article-title":"The role of IFN in the development of NAFLD and NASH","volume":"124","author":"M\u00f8hlenberg","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.bmcl.2021.128464_b0050","doi-asserted-by":"crossref","unstructured":"Bioactivatable Pseudotripeptidization of Cyclic Dipeptides To Increase the Affinity toward Oligopeptide Transporter 1 for Enhanced Oral Absorption: An Application to Cyclo(l-Hyp-l-Ser) (JBP485). Journal of medicinal chemistry. 2019;62(17): 7708-7721.","DOI":"10.1021\/acs.jmedchem.9b00358"},{"issue":"5","key":"10.1016\/j.bmcl.2021.128464_b0055","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.peptides.2011.01.031","article-title":"Effects of JBP485 on the expression and function of PEPT1 in indomethacin-induced intestinal injury in rats and damage in Caco-2 cells","volume":"32","author":"Wang","year":"2011","journal-title":"Peptides"},{"issue":"11","key":"10.1016\/j.bmcl.2021.128464_b0060","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1248\/bpb.31.2040","article-title":"Laennec protects murine from concanavalin a-induced liver injury through inhibition of inflammatory reactions and hepatocyte apoptosis","volume":"31","author":"Wu","year":"2008","journal-title":"Biol Pharm Bull"},{"issue":"2","key":"10.1016\/j.bmcl.2021.128464_b0065","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0022-3565(24)39100-1","article-title":"Hydroxyprolylserine derivatives JBP923 and JBP485 exhibit the antihepatitis activities after gastrointestinal absorption in rats","volume":"294","author":"Liu","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bmcl.2021.128464_b0070","doi-asserted-by":"crossref","unstructured":"Parola M, Muraca R, Dianzani I, et al. Vitamin E dietary supplementation inhibits transforming growth factor \u03b21 gene expression in the rat liver. FEBS Letters. 1992;308(3): 267-270.","DOI":"10.1016\/0014-5793(92)81290-3"},{"issue":"9","key":"10.1016\/j.bmcl.2021.128464_b0075","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.nut.2014.01.016","article-title":"Effect of vitamin E supplementation on aminotransferase levels in patients with NAFLD, NASH, and CHC: Results from a meta-analysis","volume":"30","author":"Ji","year":"2014","journal-title":"Nutrition"},{"issue":"5","key":"10.1016\/j.bmcl.2021.128464_b0080","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1194\/jlr.RA119000183","article-title":"Vitamin E does not prevent Western diet-induced NASH progression and increases metabolic flux dysregulation in mice","volume":"61","author":"Hasenour","year":"2020","journal-title":"J Lipid Res"},{"key":"10.1016\/j.bmcl.2021.128464_b0085","doi-asserted-by":"crossref","first-page":"172913","DOI":"10.1016\/j.ejphar.2020.172913","article-title":"Challenges and opportunities in drug development for nonalcoholic steatohepatitis","volume":"870","author":"Ocker","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bmcl.2021.128464_b0090","first-page":"1","article-title":"Salidroside modulates insulin signaling in a rat model of nonalcoholic steatohepatitis","volume":"2017","author":"Li","year":"2017","journal-title":"Evid Based Complement Alternative Med eCAM."},{"issue":"13","key":"10.1016\/j.bmcl.2021.128464_b0095","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1021\/acs.jafc.7b06146","article-title":"Effects of stigmasterol and beta-sitosterol on nonalcoholic fatty liver disease in a mouse model: a lipidomic analysis","volume":"66","author":"Feng","year":"2018","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.bmcl.2021.128464_b0100","doi-asserted-by":"crossref","first-page":"111610","DOI":"10.1016\/j.ecoenv.2020.111610","article-title":"Vitamin E protects against cadmium-induced sub-chronic liver injury associated with the inhibition of oxidative stress and activation of Nrf2 pathway","volume":"208","author":"Fang","year":"2021","journal-title":"Ecotoxicol. Environ. Saf."}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21006910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21006910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:42:49Z","timestamp":1760773369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X21006910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":20,"alternative-id":["S0960894X21006910"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128464","relation":{},"ISSN":["0960-894X"],"issn-type":[{"type":"print","value":"0960-894X"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and activity evaluation of prodrug form JBP485 and Vitamin E for alleviation of NASH","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128464","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128464"}}